rHSC-DIPGVax(rHSC-DIPGVax)

N/A

Report date: 2022/11/27 13:48:47

Base Information

Drug NamerHSC-DIPGVax(rHSC-DIPGVax)
Drug Alias NameN/A
ClassificationVaccines
Mechanisms of ActionHeat-shock protein modulatorsImmunostimulants
TargetsHeat-shock protein
Therapy Area/IndicationsDiffuse midline gliomaDiffuse Intrinsic Pontine Glioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAnn & Robert H Lurie Children'S Hospital Of Chicago
China Registration ClassN/A

Develop Information

Active CompaniesAnn & Robert H Lurie Children'S Hospital Of Chicago
Inactive CompaniesN/A
Active IndicationsDiffuse midline gliomaDiffuse Intrinsic Pontine Glioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A